Send feedback

DAAM2 p.Ala989Val

c.2966C>T · rs755311083 · VCV2401617

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.1225 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0518%, mid)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
1
Inborn genetic diseases

Computational evidence

Protein change
AlphaMissense0.1225likely benign
REVEL0.387indeterminate
SaProtLLR -8.31tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAIΔ0.24donor gain · deltas
PangolinΔ0.21gain · loss 0.01 · agrees with SpliceAI · independent
Constraint at this position
ConservationphyloP 2.2GERP 2.5, phastCons 0.98
Regional constrainto/e 0.97unconstrained · MANE · 24 kb · p 0.46 · regional, not allelic
Overall
CADD24.1PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0518% Middle Eastern · 3/5,788 alleles
Filtering AF 0.0141% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00752%
Overall 0.0106% 170/1,607,974 alleles · ultra-rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.413% 242
Middle Easterngrpmax 0.0518% 1,929
Remaining individualsnot grpmax-eligible 0.024% 4,158
African / African-American 0.0134% 7,489
Admixed American 0.005% 19,985
European (non-Finnish) 0.00136% 73,708
South Asian 0.0011% 90,854

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
DAAM2
Protein
p.Ala989Val
Coding
c.2966C>T
MANE Select
NM_001201427
dbSNP
rs755311083
Type
single nucleotide variant
Location
chr6:39901456 (GRCh38)
Gene constraint
LOEUF 0.488 · pLI 0.98 (gnomAD)
Structure
AlphaFold pLDDT 80.02
Residue 989
a UniProt-annotated variant site (in nphs24; affects the regulation of filopodia formation); the fh2 domain
Full DAAM2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/daam2-p-ala989val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown